# Resistance to Oral Therapy in Lung Cancer

> **NCT04546282** · — · COMPLETED · sponsor: **University Hospital, Montpellier** · enrollment: 20 (actual)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **OTHER:** Description of the molecular alterations detected in blood samples of patients treated by osimertinib

## Key facts

- **NCT ID:** NCT04546282
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-01
- **Primary completion:** 2020-07-01
- **Final completion:** 2020-11-28
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2020-12-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04546282

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04546282, "Resistance to Oral Therapy in Lung Cancer". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT04546282. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*